Company
Cognition Therapeutics
- Business model
- B2B
Record updated 28 September 2026
About
(NASDAQ: CGTX) is a clinical-stage biopharmaceutical company focused on synaptic health and restoration in neurodegenerative disorders through a pipeline of disease modifying small molecule drug candidates.